Literature DB >> 18453125

Cell-free assays: the reductionist approach to the study of NADPH oxidase assembly, or "all you wanted to know about cell-free assays but did not dare to ask".

Shahar Molshanski-Mor1, Ariel Mizrahi, Yelena Ugolev, Iris Dahan, Yevgeny Berdichevsky, Edgar Pick.   

Abstract

The superoxide (O2-)-generating enzyme complex of phagocytes, known as the NADPH oxidase, can be assayed in a number of in vitro cell-free (or broken cell) systems. These consist of a mixture of the individual components of the NADPH oxidase, derived from resting phagocytes or in the form of purified recombinant proteins, exposed to an activating agent (or situation), in the presence of NADPH and oxygen. O2- produced by the mixture is measured by being trapped immediately after its generation with an appropriate acceptor in a kinetic assay, which permits the calculation of the linear rate of O2- production over time. Cell-free assays are distinguished from whole-cell assays or assays performed on membranes derived from stimulated cells by the fact that all components in the reaction are derived from resting, nonstimulated cells and, thus, the steps of NADPH oxidase activation (precatalytic [assembly] and catalytic) occur in vitro. Cell-free assays played a paramount role in the identification of the components of the NADPH oxidase complex, the diagnosis of various forms of chronic granulomatous disease (CGD), and, more recently, the analysis of the domains present on the components of the NADPH oxidase participating in protein-protein interactions leading to the assembly of the active complex.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18453125     DOI: 10.1007/978-1-59745-467-4_25

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  16 in total

Review 1.  Molecular diagnosis of chronic granulomatous disease.

Authors:  D Roos; M de Boer
Journal:  Clin Exp Immunol       Date:  2014-02       Impact factor: 4.330

2.  Selective inactivation of NADPH oxidase 2 causes regression of vascularization and the size and stability of atherosclerotic plaques.

Authors:  I M Quesada; A Lucero; C Amaya; D N Meijles; M E Cifuentes; P J Pagano; C Castro
Journal:  Atherosclerosis       Date:  2015-08-08       Impact factor: 5.162

3.  Nox2-Mediated PI3K and Cofilin Activation Confers Alternate Redox Control of Macrophage Pinocytosis.

Authors:  Pushpankur Ghoshal; Bhupesh Singla; Huiping Lin; Douglas M Feck; Nadiezhda Cantu-Medellin; Eric E Kelley; Stephen Haigh; David Fulton; Gábor Csányi
Journal:  Antioxid Redox Signal       Date:  2016-09-13       Impact factor: 8.401

4.  Nox2 B-loop peptide, Nox2ds, specifically inhibits the NADPH oxidase Nox2.

Authors:  Gábor Csányi; Eugenia Cifuentes-Pagano; Imad Al Ghouleh; Daniel J Ranayhossaini; Loreto Egaña; Lucia R Lopes; Heather M Jackson; Eric E Kelley; Patrick J Pagano
Journal:  Free Radic Biol Med       Date:  2011-04-17       Impact factor: 7.376

5.  G6PC3 mutations are associated with a major defect of glycosylation: a novel mechanism for neutrophil dysfunction.

Authors:  Bu'hussain Hayee; Aristotelis Antonopoulos; Emma J Murphy; Farooq Z Rahman; Gavin Sewell; Bradley N Smith; Sara McCartney; Mark Furman; Georgina Hall; Stuart L Bloom; Stuart M Haslam; Howard R Morris; Kaan Boztug; Christoph Klein; Bryan Winchester; Edgar Pick; David C Linch; Rosemary E Gale; Andrew M Smith; Anne Dell; Anthony W Segal
Journal:  Glycobiology       Date:  2011-03-08       Impact factor: 4.313

6.  Nox-derived ROS are acutely activated in pressure overload pulmonary hypertension: indications for a seminal role for mitochondrial Nox4.

Authors:  Giovanna Frazziano; Imad Al Ghouleh; Jeff Baust; Sruti Shiva; Hunter C Champion; Patrick J Pagano
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-11-08       Impact factor: 4.733

7.  Bridged tetrahydroisoquinolines as selective NADPH oxidase 2 (Nox2) inhibitors.

Authors:  Eugenia Cifuentes-Pagano; Jaideep Saha; Gábor Csányi; Imad Al Ghouleh; Sanghamitra Sahoo; Andrés Rodríguez; Peter Wipf; Patrick J Pagano; Erin M Skoda
Journal:  Medchemcomm       Date:  2013-07       Impact factor: 3.597

Review 8.  Role of the Rho GTPase Rac in the activation of the phagocyte NADPH oxidase: outsourcing a key task.

Authors:  Edgar Pick
Journal:  Small GTPases       Date:  2014-03-05

Review 9.  Detection of superoxide anion and hydrogen peroxide production by cellular NADPH oxidases.

Authors:  William M Nauseef
Journal:  Biochim Biophys Acta       Date:  2013-05-07

Review 10.  Strategies for identifying synthetic peptides to act as inhibitors of NADPH oxidases, or "all that you did and did not want to know about Nox inhibitory peptides".

Authors:  Iris Dahan; Edgar Pick
Journal:  Cell Mol Life Sci       Date:  2012-05-06       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.